Publications by authors named "Justin Doan"

Claim this Profile
R
Real-world clinical outcomes associated with first-line palbociclib and aromatase inhibitor therapy among patients with HR+/HER2- advanced breast cancer in Europe.
Olga Oikonomidou, Mark J Beresford, Elena Galve-Calvo, Achim Woeckel, Rohan C Parikh, Justin Doan

Breast Cancer Res Treat· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world study of patients with HR+/ HER2- metastatic breast cancer treated with palbociclib and fulvestrant.
Nicholas Robert, Connie Chen, Justin Doan, Divea Venkatasetty, Janet L Espirito

Future Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of COVID-19 on patients with metastatic breast cancer: REthink Access to Care and Treatment survey results.
Neil M Iyengar, Clay Williams, Michael Rogan, Laurie Campbel, Shirley Mertz, Justin Doan

Future Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic review of health-related quality of life outcomes in patients with advanced breast cancer treated with palbociclib.
Imtiaz A Samjoo, Alexandra Hall, Connie Chen, Bao-Ngoc Nguyen, Meaghan Bartlett, Justin Doan

J Comp Eff Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment sequences for advanced renal cell carcinoma: A health economic assessment.
Baris Deniz, Apoorva Ambavane, Shuo Yang, Arman Altincatal, Justin Doan

PLoS One· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating Partitioned Survival and Markov Decision-Analytic Modeling Approaches for Use in Cost-Effectiveness Analysis: Estimating and Comparing Survival Outcomes.
Caitlin Smare, Khalid Lakhdari, Justin Doan, John Posnett, Sukhvinder Johal

Pharmacoeconomics· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of treatment in patients with stage IV renal cell carcinoma.
Christopher S Hollenbeak, Eric W Schaefer, Justin Doan, Jay D Raman

BMC Urol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Quality-adjusted Time Without Symptoms or Toxicity (Q-TWiST) Analysis of Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma (aRCC).
Ruchitbhai Shah, Marc Botteman, Caitlyn T Solem, Linlin Luo, Justin Doan

Clin Genitourin Cancer· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of dynamic modeling for survival estimation in advanced renal cell carcinoma.
Baris Deniz, Arman Altincatal, Apoorva Ambavane, Sumati Rao, Justin Doan

PLoS One· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcomes of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib (CheckMate 214): a randomised, phase 3 trial.
David Cella, Viktor Grünwald, Bernard Escudier, Hans J Hammers, Saby George, Justin Doan

Lancet Oncol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing the Relative Importance of Attributes of Metastatic Renal Cell Carcinoma Treatments to Patients and Physicians in the United States: A Discrete-Choice Experiment.
Juan Marcos González, Justin Doan, David J Gebben, Marco Boeri, Mayer Fishman

Pharmacoeconomics· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma.
Robert J Motzer, Nizar M Tannir, David F McDermott, Osvaldo Arén Frontera, Bohuslav Melichar, Justin Doan

N Engl J Med· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of nivolumab in patients with advanced renal cell carcinoma treated in the United States.
Charles McCrea, Sukhvinder Johal, Shuo Yang, Justin Doan

Exp Hematol Oncol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of medication nonadherence on progression-free survival among patients with renal cell carcinoma.
Jason Shafrin, Jeffrey Sullivan, Jacquelyn W Chou, Michael N Neely, Justin F Doan

Cancer Manag Res· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Beyond Progression in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab in CheckMate 025.
Bernard Escudier, Robert J Motzer, Padmanee Sharma, John Wagstaff, Elizabeth R Plimack, Justin Doan

Eur Urol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life in patients with advanced renal cell carcinoma given nivolumab versus everolimus in CheckMate 025: a randomised, open-label, phase 3 trial.
David Cella, Viktor Grünwald, Paul Nathan, Justin Doan, Homa Dastani

Lancet Oncol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of central nervous system metastases on treatment discontinuation and survival in older women receiving trastuzumab for metastatic breast cancer.
Mark D Danese, Karla Lindquist, Justin Doan, Deepa Lalla, Melissa Brammer

J Cancer Epidemiol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infused therapy and survival in older patients diagnosed with metastatic breast cancer who received trastuzumab.
Robert I Griffiths, Deepa Lalla, Robert J Herbert, Justin F Doan, Melissa G Brammer

Cancer Invest· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insomnia medication use and the probability of an accidental event in an older adult population.
Alon Y Avidan, Liisa A Palmer, Justin F Doan, Robert W Baran

Drug Healthc Patient Saf· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the reliability and validity of a newly developed insomnia treatment satisfaction questionnaire (ITSAT-Q).
Andrew P Beyer, Sheryl L Szeinbach, Enrique C Seoane-Vazquez, Joseph A Gliem, Justin Doan

Sleep Med· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health benefit costs and absenteeism due to insomnia from the employer's perspective: a retrospective, case-control, database study.
Nathan L Kleinman, Richard A Brook, Justin F Doan, Arthur K Melkonian, Robert W Baran

J Clin Psychiatry· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of insomnia with quality of life, work productivity, and activity impairment.
Susan C Bolge, Justin F Doan, Hema Kannan, Robert W Baran

Qual Life Res· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis